NIH-funded research R21 grant

Understanding how genetic differences affect susceptibility to Zika virus

Official title: Human Genetic Variation Regulating Cellular Susceptibility to Zika Virus

Funded at Duke University · NIH-11096079 · Data updated 2026-11-12

This study is looking at how our genes might affect how we respond to Zika virus infections, especially in people of African descent, to help find ways to better protect those at risk of serious health issues from the virus.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startJune 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$200,269
NIH project number5R21AI185498-02
Project IDNIH-11096079 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals of African descent or those with a family history of severe Zika virus outcomes.

Less likely to help

Patients who are not of African descent or those who have not been affected by Zika virus may not receive direct benefits from this research.

What this research studies

This research investigates the role of human genetic variation in determining how individuals respond to Zika virus infections. By examining genetic differences among people, particularly those of African descent, the study aims to identify specific alleles that may influence susceptibility to the virus and its severe outcomes, such as congenital Zika syndrome. The approach includes genome-wide association studies and in vitro experiments using cells from individuals with different genetic backgrounds. This research could lead to better understanding and potentially personalized treatments for those at risk of severe Zika virus outcomes.

Why it matters

Potential benefit: If successful, this research could provide insights that lead to targeted prevention strategies and treatments for individuals at higher risk of severe Zika virus infections.

How similar studies have gone: While there have been successful studies on genetic susceptibility to other viral infections, this specific approach to Zika virus is novel and has not been extensively tested.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Ko, Dennis Chun-Yone — Duke University
  • Study coordinator: Ko, Dennis Chun-Yone

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.